Response to commentary on "pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors".
作者信息
Barcellos Marcio, Braga Antonio, Rech Matheus Machado, de Oliveira Solange Artimos, Madi Jose Mauro, Sun Sue Yazaki, de Rezende-Filho Jorge, Elias Kevin M, Horowitz Neil S, Berkowitz Ross S
机构信息
Rio de Janeiro Trophoblastic Disease Center, Maternidade Escola da Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Postgraduate Program in Medical Sciences, Faculdade de Medicina da Universidade Federal Fluminense, Rio de Janeiro, RJ, Brazil.
Rio de Janeiro Trophoblastic Disease Center, Maternidade Escola da Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Postgraduate Program in Medical Sciences, Faculdade de Medicina da Universidade Federal Fluminense, Rio de Janeiro, RJ, Brazil; Postgraduate Program in Applied Health Sciences, Universidade Vassouras, Vassouras, RJ, Brazil.
出版信息
Clinics (Sao Paulo). 2025 Jun 27;80:100713. doi: 10.1016/j.clinsp.2025.100713.
Abstract
摘要
相似文献
1
Response to commentary on "pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors".对《帕博利珠单抗治疗妊娠滋养细胞肿瘤：系统评价与荟萃分析及潜在预后因素亚组分析》评论的回应
Clinics (Sao Paulo). 2025 Jun 27;80:100713. doi: 10.1016/j.clinsp.2025.100713.
2
Effect of lung metastasis on the treatment and prognosis of patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis.肺转移对妊娠滋养细胞肿瘤患者治疗和预后的影响：系统评价和荟萃分析。
Acta Obstet Gynecol Scand. 2024 Apr;103(4):636-644. doi: 10.1111/aogs.14789. Epub 2024 Jan 28.
3
Second curettage versus conventional chemotherapy in avoiding unnecessary chemotherapy and reducing the number of chemotherapy courses for patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis.二次刮宫与常规化疗在避免不必要化疗和减少妊娠滋养细胞肿瘤患者化疗疗程数中的作用：系统评价和荟萃分析。
Int J Gynaecol Obstet. 2024 Apr;165(1):34-42. doi: 10.1002/ijgo.15140. Epub 2023 Sep 27.
4
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis.仑伐替尼联合帕博利珠单抗治疗未经治疗的晚期肾细胞癌：系统评价和成本效果分析。
Health Technol Assess. 2024 Aug;28(49):1-190. doi: 10.3310/TRRM4238.
5
Treatments and outcomes in high-risk gestational trophoblastic neoplasia: A systematic review and meta-analysis.高危型妊娠滋养细胞肿瘤的治疗和结局：系统评价和荟萃分析。
BJOG. 2023 Apr;130(5):443-453. doi: 10.1111/1471-0528.17374. Epub 2023 Jan 25.
6
Contraceptive use following gestational trophoblastic disease: A systematic review.妊娠滋养细胞疾病后避孕方法的使用：系统评价。
Contraception. 2024 Sep;137:110488. doi: 10.1016/j.contraception.2024.110488. Epub 2024 May 17.
7
Fertility-sparing surgical interventions for low-risk, non-metastatic gestational trophoblastic neoplasia.低危、非转移性妊娠滋养细胞肿瘤的保留生育功能的手术干预。
Cochrane Database Syst Rev. 2024 Sep 23;9(9):CD014755. doi: 10.1002/14651858.CD014755.pub2.
8
First-line chemotherapy in low-risk gestational trophoblastic neoplasia.低危妊娠滋养细胞肿瘤的一线化疗
Cochrane Database Syst Rev. 2016 Jun 9;2016(6):CD007102. doi: 10.1002/14651858.CD007102.pub4.
9
Pembrolizumab in gestational trophoblastic neoplasia: Systematic review and meta-analysis with sub-group analysis of potential prognostic factors.帕博利珠单抗治疗妊娠滋养细胞肿瘤：系统评价与荟萃分析及潜在预后因素的亚组分析
Clinics (Sao Paulo). 2025 Mar 2;80:100583. doi: 10.1016/j.clinsp.2025.100583. eCollection 2025.
10
Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.联合化疗用于高危妊娠滋养细胞肿瘤的初始治疗
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD005196. doi: 10.1002/14651858.CD005196.pub4.
本文引用的文献
1
Commentary on "Pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors".关于“帕博利珠单抗治疗妊娠滋养细胞肿瘤：系统评价与荟萃分析及潜在预后因素亚组分析”的述评
Clinics (Sao Paulo). 2025 Apr 24;80:100651. doi: 10.1016/j.clinsp.2025.100651. eCollection 2025.
2
Pembrolizumab in gestational trophoblastic neoplasia: Systematic review and meta-analysis with sub-group analysis of potential prognostic factors.帕博利珠单抗治疗妊娠滋养细胞肿瘤：系统评价与荟萃分析及潜在预后因素的亚组分析
Clinics (Sao Paulo). 2025 Mar 2;80:100583. doi: 10.1016/j.clinsp.2025.100583. eCollection 2025.
3
LFK index does not reliably detect small-study effects in meta-analysis: A simulation study.LFK指数在荟萃分析中无法可靠地检测小研究效应：一项模拟研究。
Res Synth Methods. 2024 Jul;15(4):603-615. doi: 10.1002/jrsm.1714. Epub 2024 Mar 11.
4
Immunotherapy in the treatment of chemoresistant gestational trophoblastic neoplasia - systematic review with a presentation of the first 4 Brazilian cases.免疫疗法治疗化疗耐药性妊娠滋养细胞肿瘤-系统评价及 4 例巴西首例病例报告。
Clinics (Sao Paulo). 2023 Jul 29;78:100260. doi: 10.1016/j.clinsp.2023.100260. eCollection 2023.
5
An overview of the impact of rare disease characteristics on research methodology.罕见病特征对研究方法影响概述。
Orphanet J Rare Dis. 2018 Jan 19;13(1):14. doi: 10.1186/s13023-017-0755-5.
6
Random effects meta-analysis: Coverage performance of 95% confidence and prediction intervals following REML estimation.随机效应荟萃分析：采用限制最大似然估计后95%置信区间和预测区间的覆盖性能。
Stat Med. 2017 Jan 30;36(2):301-317. doi: 10.1002/sim.7140. Epub 2016 Oct 7.
7
Plea for routinely presenting prediction intervals in meta-analysis.呼吁在荟萃分析中常规呈现预测区间。
BMJ Open. 2016 Jul 12;6(7):e010247. doi: 10.1136/bmjopen-2015-010247.
8
Interpretation of random effects meta-analyses.随机效应荟萃分析的解读
BMJ. 2011 Feb 10;342:d549. doi: 10.1136/bmj.d549.
Zotero 插件